{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:05:30Z","timestamp":1770883530477,"version":"3.50.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>\n                    Chylomicron retention disease (CMRD) is a rare autosomal recessive disorder caused by pathogenic variants of\n                    <jats:italic>SAR1B<\/jats:italic>\n                    , in which defective intestinal chylomicron secretion leads to fat malabsorption, hypocholesterolemia, and failure to thrive in infancy. Its diagnosis is typically challenging because of its rarity, nonspecific early symptoms, and overlap with other metabolic and malabsorptive disorders. The present case is notable for its neonatal onset with isolated failure to gain weight and the absence of persistent diarrhea or steatorrhea, complicating early clinical suspicion. Initial metabolic screening revealed overlapping abnormalities with urea cycle disorders and fatty acid oxidation defects, underscoring diagnostic complexity. A definitive diagnosis was achieved through the identification of compound heterozygous likely pathogenic\n                    <jats:italic>SAR1B<\/jats:italic>\n                    variants, c.258G\u2009&amp;gt;\u2009A (p.Trp86Ter) and c.442C\u2009&amp;gt;\u2009T (p.Arg148Ter), thereby expanding the known phenotypic and genotypic spectrum of CMRD. The patient exhibited marked clinical and biochemical improvements following timely intervention with a low-fat, medium-chain triglyceride(MCT)-enriched diet and fat-soluble vitamin supplementation. However, subsequent follow-up revealed suboptimal adherence to the dietary regimen, leading to the emergence of typical steatorrhea, persistent growth failure, and neurodevelopmental delay, highlighting the critical and sustained role of strict nutritional management. This case highlights the importance of heightened clinical vigilance, timely genetic testing, and the necessity of ensuring long-term treatment adherence in infants presenting with unexplained growth failure and subtle hepatic abnormalities even when classic symptoms are absent. Taken together, this study provides valuable insights into the diagnostic challenges, therapeutic pitfalls, and management strategies of CMRD, emphasizing the need for multidisciplinary collaboration, enhanced awareness among clinicians, and further research to elucidate genotype-phenotype correlations and optimize patient care.\n                  <\/jats:p>","DOI":"10.3389\/fped.2026.1684900","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:15:25Z","timestamp":1770880525000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Neonatal-onset chylomicron retention disease presenting as isolated failure to thrive with compound heterozygous SAR1B variants: the value of early genetic testing and challenges of long-term management"],"prefix":"10.3389","volume":"14","author":[{"given":"Bing","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Neonatology, Weifang Maternal and Child Health Hospital","place":["Weifang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Weifang Maternal and Child Health Hospital","place":["Weifang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e7184","DOI":"10.7759\/cureus.7184","article-title":"Chylomicron retention disease in a male infant: a rare case from Pakistan","volume":"12","author":"Kumar","year":"2020","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3760\/cma.j.cn112140-20240301-00138","article-title":"Chylomicron retention disease caused by SAR1B gene variations in 2 cases and literatures review","volume":"62","author":"Zhang","year":"2024","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-6-1","article-title":"Molecular analysis and intestinal expression of SAR1B genes and proteins in Anderson\u2019s disease (chylomicron retention disease)","volume":"6","author":"Georges","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ymgme.2007.08.120","article-title":"Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein","volume":"93","author":"Charcosset","year":"2008","journal-title":"Mol Genet Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1399-0004.2008.01069.x","article-title":"Anderson\u2019s disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities","volume":"74","author":"Silvain","year":"2008","journal-title":"Clin Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1194\/jlr.M085043","article-title":"Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease","volume":"59","author":"Cuerq","year":"2018","journal-title":"J Lipid Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1750-1172-6-78","article-title":"Anderson\u2019s disease\/chylomicron retention disease in a Japanese patient with uniparental disomy 7 and a normal SAR1B gene protein coding sequence","volume":"6","author":"Okada","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jacl.2019.05.013","article-title":"Novel mutations of SAR1B gene in four children with chylomicron retention disease","volume":"13","author":"Simone","year":"2019","journal-title":"J Clin Lipidol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12887-021-02897-5","article-title":"Chylomicron retention disease caused by a new pathogenic variant in sar1b protein: a rare case report from Syria","volume":"21","author":"Doya","year":"2021","journal-title":"BMC Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MOL.0000000000000578","article-title":"Chylomicron retention disease: genetics, biochemistry, and clinical spectrum","volume":"30","author":"Levy","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5223\/pghn.2018.21.2.134","article-title":"Chylomicron retention disease: a description of a new mutation in a very rare disease","volume":"21","author":"Ferreira","year":"2018","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1097\/PG9.0000000000000145","article-title":"Chylomicron retention disease: failure to thrive and abdominal distention in an infant","volume":"3","author":"Nayak","year":"2022","journal-title":"JPGN Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.metabol.2009.07.042","article-title":"Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene","volume":"59","author":"Cefal\u00f9","year":"2010","journal-title":"Metab Clin Exp"},{"key":"B14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/1531-8249(200002)47:2%3C260::AID-ANA21%3E3.0.CO;2-V","article-title":"Vitamin E deficiency due to chylomicron retention disease in Marinesco-Sj\u00f6gren syndrome","volume":"47","author":"Aguglia","year":"2000","journal-title":"Ann Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/s0035-3787(07)92632-6","article-title":"Urea cycle disorders in adult patients","volume":"163","author":"Maillot","year":"2007","journal-title":"Rev Neurol (Paris)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408360091174169","article-title":"Inborn errors of mitochondrial fatty acid oxidation","volume":"37","author":"Bennett","year":"2000","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1386695","DOI":"10.3389\/fneur.2024.1386695","article-title":"Hyperbaric oxygen therapy for the treatment of hypoxic\/ischemic injury upon perinatal asphyxia-are we there yet?","volume":"15","author":"Mielecki","year":"2024","journal-title":"Front Neurol"},{"key":"B18","first-page":"812","article-title":"Perinatal asphyxia, hypoxic-ischemic encephalopathy and neurological sequelae in full-term newborns: an epidemiological study (1)","volume":"24","author":"Gonz\u00e1lez de Dios","year":"1996","journal-title":"Rev Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1515\/jpem-2017-0426","article-title":"The safety of lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study","volume":"31","author":"MacDonald","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00109-014-1247-x","article-title":"Animal model of Sar1b deficiency presents lipid absorption deficits similar to Anderson disease","volume":"93","author":"Levic","year":"2015","journal-title":"J Mol Med (Berl)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"100423","DOI":"10.1016\/j.jlr.2023.100423","article-title":"High-fat diet reveals the impact of Sar1b defects on lipid and lipoprotein profile and cholesterol metabolism","volume":"64","author":"Auclair","year":"2023","journal-title":"J Lipid Res"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1684900\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:15:30Z","timestamp":1770880530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1684900\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":21,"alternative-id":["10.3389\/fped.2026.1684900"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1684900","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"article-number":"1684900"}}